Non-opioid Pain Patch Market Size

  • Report ID: 5423
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Non-opioid Pain Patch Market Size

Non-opioid Pain Patch Market size was valued at USD 3.61 billion in 2024 and is likely to reach USD 6.16 billion by the end of 2037, registering around 4.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of non-opioid pain patch is assessed at USD 3.73 billion.

The reason behind the growth is due to the growing burden of diabetes across the globe. Diabetic neuropathy may present as the initial symptom of diabetes caused by excessive blood sugar levels that harm the nerves resulting in pain and discomfort in the hands, feet, or limbs.

According to the World Health Organization (WHO), around 422 million individuals globally suffer from diabetes, and the disease is directly responsible for roughly 1.5 million fatalities annually.

The growing development of advanced products is believed to fuel the non-opioid pain patch market growth. For instance, A scientific team led by Duke University has created a biocompatible polymer patch surgical patch that dissolves after releasing non-opioid medicines and it is assumed that during the crucial period following surgery, the patch should be able to manage wound discomfort for three or four days.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5423
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of non-opioid pain patch is assessed at USD 3.73 billion.

The non-opioid pain patch market size was valued at USD 3.61 billion in 2024 and is likely to reach USD 6.16 billion by the end of 2037, registering around 4.2% CAGR during the forecast period i.e., between 2025-2037. Growing burden of diabetes across the globe and The growing development of advanced products will drive the market growth.

North America industry is likely to dominate majority revenue share 51% by 2037, impelled by presence of key players which has led to the development of new products in the region.

The major players in the market are GlaxoSmithKline Plc., Pfizer Inc., Hisamitsu Pharmaceutical Co., Inc., Clarion Brands, Endo Pharmaceuticals, TEH SENG Pharmaceutical, Teva Pharmaceutical Industries Ltd., Teikoku Seiyaku Co. Ltd., Veridian Healthcare, Sorrento Therapeutics (SCILEX Pharmaceuticals Inc., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample